TrialBMJ open2017

Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial.

L J Bonnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.